Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows
byDana-Farber Cancer InstituteNew research shows that genetics account for only five to 10 per cent of risk for most human diseases, and that gene testing is a poor predictor of whether someone
Updated on: January 04,2024
9
Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows
byDana-Farber Cancer InstituteNew research shows that genetics account for only five to 10 per cent of risk for most human diseases, and that gene testing is a poor predictor of whether someone
Updated on:January 04,2024
9
